Senior insider sale
FULCRUM THERAPEUTICS, INC. — senior position signals high conviction
$65.0K
18K shares
What this filing means
EZEKOWITZ ALAN plans to sell 18K shares of FULCRUM THERAPEUTICS, INC. valued at approximately $65.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/26/2026ACC: 0001950047-26-006549
18K
Shares to sell
$65.0K
Approx. market value
18K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/15/2017
18KTotal acquired18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2017 | Restricted Stock Units N/A | 18K | — |
| Total | 18K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
18K
Market value
$65.0K
6/26/2026
Total
Units
18K
Value
$65.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/26/2026 | 18K | $65.0K | NASDAQ | Planned |
| Total | 18K | $65.0K | ||